Insider Transactions in Q4 2024 at Bristol Myers Squibb CO (BMY)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 04
2024
|
Phil M Holzer SVP and Controller |
SELL
Open market or private sale
|
Direct |
700
-5.62%
|
$38,500
$55.62 P/Share
|
|
Nov 01
2024
|
Samit Hirawat EVP,Chief Med.Offr.,Drug Dev. |
BUY
Open market or private purchase
|
Direct |
1,830
+2.86%
|
$98,820
$54.67 P/Share
|
|
Nov 01
2024
|
Christopher S. Boerner Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,488
-1.43%
|
$80,352
$54.32 P/Share
|
|
Nov 01
2024
|
Christopher S. Boerner Chief Executive Officer |
SELL
Other acquisition or disposition
|
Direct |
55
-0.05%
|
-
|
|
Nov 01
2024
|
Christopher S. Boerner Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,964
+2.77%
|
-
|
|
Oct 02
2024
|
Cari Gallman EVP, Corporate Affairs |
SELL
Payment of exercise price or tax liability
|
Direct |
1,648
-24.72%
|
$87,344
$53.76 P/Share
|
|
Oct 02
2024
|
Cari Gallman EVP, Corporate Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
4,558
+40.61%
|
-
|